Edgewell Personal Care CO

Edgewell Personal Care Company has announced a change in its Chief Supply Chain Officer role, with Paul R. Hibbert departing and Anthony Freve appointed to the position.

Edgewell Personal Care announced second quarter fiscal 2026 results, with net sales and adjusted EPS exceeding expectations, while reaffirming full-year financial outlook.

Edgewell Personal Care reported first quarter fiscal 2026 results ahead of expectations, successfully completed its Feminine Care divestiture, and reaffirmed its full-year outlook for continuing operations.

Edgewell Personal Care Company has completed the sale of its Feminine Care business to Essity for $340 million, aiming to strengthen its balance sheet and focus on core brands.

Edgewell Personal Care announced its fourth quarter and fiscal year 2025 results, revealing mixed performance with a net sales decrease for the full year but organic growth in Q4, alongside the strategic divestiture of its Feminine Care business and a new share repurchase authorization.

Edgewell Personal Care Company announced a definitive agreement to sell its Feminine Care business, including Playtex, Stayfree, Carefree, and o.b. brands, to Essity for $340 million in cash.

Edgewell Personal Care reports a net loss for the quarter driven by restructuring charges and a decline in adjusted earnings, despite a slight increase in net sales.

Edgewell Personal Care Company reported a significant net loss in Q1 fiscal 2026, primarily driven by a goodwill impairment charge related to its Feminine Care divestiture and increased restructuring costs.

Edgewell Personal Care Company reported a significant decline in third-quarter net earnings and sales, driven by volume decreases and increased promotional activity in North America.

Edgewell Personal Care's Q2 fiscal 2025 net sales decreased by 3.1% to $580.7 million, with restructuring and repositioning actions ongoing.

Edgewell Personal Care's Q1 2025 net sales decreased by 2.1% to $478.4 million, with a net loss of $2.1 million, as the company continues to execute its restructuring and repositioning plans.

Edgewell Personal Care's third-quarter results show a slight decrease in net sales, with international growth partially offsetting declines in North America.

Edgewell Personal Care Company reported a 74.2% drop in net earnings for fiscal 2025, alongside a 1.3% net sales decrease and a strategic divestiture of its Feminine Care segment.

Edgewell Personal Care Company filed an amendment to its annual report to include previously omitted exhibits and new certifications from its CEO and CFO.

Edgewell Personal Care's annual 10-K filing reveals a slight increase in net sales, offset by challenges in North America and restructuring efforts, while also highlighting strategic executive changes.

Edgewell Personal Care Company director Swan Sit acquired 7,817 restricted stock equivalents, aligning interests with shareholders.

Edgewell Personal Care Co. Director Rakesh Sachdev was granted 7,817 restricted stock equivalents, enhancing his beneficial ownership.

Edgewell Personal Care Co. Director Stephanie Stahl acquired 7,817 restricted stock equivalents, converting to common stock, as part of her compensation.

Edgewell Personal Care Co. Director John C Hunter III was granted 7,817 restricted stock equivalents, aligning his interests with shareholders.

Edgewell Personal Care Co. director George Corbin was granted 7,817 restricted stock equivalents, converting to common stock on a future date.

Edgewell Personal Care Director Gary Waring was granted 7,817 restricted stock equivalents, convertible into common stock.

Edgewell Personal Care Company announces its 2026 Annual Meeting of Shareholders to vote on director elections, auditor ratification, executive compensation, and a stock incentive plan.

Edgewell Personal Care Company reports mixed fiscal 2025 results, marked by strategic divestiture and operational challenges, while outlining a focused plan for sustainable growth in fiscal 2026.

Edgewell Personal Care amends its proxy statement to include updated executive compensation and stock ownership information, notably adding Paul R. Hibbert as a named executive officer.

Edgewell Personal Care Company announces its 2025 Annual Meeting of Shareholders to be held on February 6, 2025, with proxy materials available online.

Edgewell Personal Care's proxy statement outlines leadership changes, strategic priorities, and strong financial performance despite a challenging external environment.

Dimensional Fund Advisors LP has disclosed a 4.0% beneficial ownership stake in Edgewell Personal Care Co., holding 1,856,415 shares.

American Century Investment Management and affiliated entities have reported an 11% beneficial ownership stake in Edgewell Personal Care Company.

Brandes Investment Partners, LP has increased its beneficial ownership of Edgewell Personal Care Co. common shares to 14.4% as of March 31, 2026.

Vanguard Capital Management has filed a Schedule 13G reporting a 5.09% beneficial ownership stake in Edgewell Personal Care Co.

Vanguard Portfolio Management has reported beneficial ownership of 3,065,063 shares, representing 6.56% of Edgewell Personal Care Co.'s common stock as of March 31, 2026.

The Vanguard Group has reported a 0% beneficial ownership stake in Edgewell Personal Care Co. following an internal realignment.